Collection · Health & Longevity

Things People Say on Podcasts About Health & Longevity

Health, medicine, biotech, and longevity.

Everything worth repeating from the Health & Longevity shows we follow. Updated every day — free to search and free to use, attribution included on every card.

The publications behind these quotes →
7
Quotes
105
Shows read
5
People quoted

Latest

Search all quotes →
“Well, what patients pay is zero. What the health care system pays is a quarter million dollars.” — Andrew Armstrong, The People's Pharmacy “Prostate cancer is the first cancer to have an AI biomarker to help make decisions in a cancer patient. It's not taking-over-the-world type AI. It's helping you live longer and better.” — Andrew Armstrong, The People's Pharmacy “You can get a lot of accolades when you generate positive clinical data, but when you try to launch your own drug, the rubber kind of hits the road. And so a little bit of commercial challenges there for Alnylam.” — Graig Suvannavejh, Biotech Hangout “We're already seeing smaller teams, virtual outsourcing, fractional C-suite, not building out big teams. I support on the venture side a couple of companies that are in clinical stage, in some cases pivotal studies, with 20 employees… I think this idea of smaller teams is here to stay. And AI is going to facilitate that.” — Chris Garabedian, Biotech Hangout “Anthropic filed an S-1 and for those of us in the biotech space, there's a surprising amount of language highlighting life sciences as sort of an explicit strategic expansion for the company… They're sort of talking about not just helping with their AI capabilities with companies that are in the development space but actually moving into drug development themselves.” — Brian Skorney, Biotech Hangout “For some relatively basic tasks where I need massive amounts of data gathered and sifted through, it is making a significant difference. I'm finding that I can displace two or three contractors, for instance, in some data gathering, which I can now do. And I still need the human in the loop to finalize the quality of the data.” — Sam Fazeli, Biotech Hangout “The real bottleneck in drug development isn't sort of target identification, drug design. The bottleneck is clinical development. And I just don't know outside of on the margins of efficiency how you're going to get around testing a year and a half or an outcome-based study in a cardiovascular disease in 10,000 patients that'll take five years to run and cost $300 million, right?” — Brian Skorney, Biotech Hangout

Most Quoted Here

Brian Skorney 2 Andrew Armstrong 2 Sam Fazeli 1 Chris Garabedian 1 Graig Suvannavejh 1